STATUTORY RULES
1971 No.
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1970.*
WHEREAS it is provided by sub-section (4.) of section 101 of the National Health Act 1953-1970 that a drug or medicinal preparation that was not a pharmaceutical benefit under the National Health Act 1953-1958 immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:
AND WHEREAS that Committee has recommended to the Minister that the following additional drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953-1970, namely, the drugs and medicinal preparations specified in the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:
NOW THEREFORE I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1970.
Dated this first day of April, 1971.
Paul Hasluck
Governor-General.
By His Excellency's Command,
Sgd.“I.J. Greenwood”
Minister of State for Health.
Amendments of the National Health (Pharmaceutical Benefits) Regulations†
Commencement.
1. These Regulations shall come into operation on the first day of April, 1971.
First, Second, Third, Fourth and Fifth Schedules.
2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—
FIRST SCHEDULE Regulation 10.
Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as or, except as specially provided, used in Pharmaceutical Benefits
1. Acetomenaphthone
2. Acetomenaphthone Tablets
3. Acetrizoic Acid
4. Alcohol Dehydrated
4a. Alcohol (95%)
4b. Allopurinol
5. Almond Oil
6. Aluminium Hydroxide Tablets
6a. Amethocaine Hydrochloride
7. Amitriptyline Injection
* Notified in the Commonwealth Gazette on 197l.
† Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1961. Nos. 12, 57 and 135; 1965, Nos, 51, 151 and 152; 1960, Nos. 80 and 144; 1967, Nos. 67, 116 and 158; 1968, Nos. 44, 76, 88 and 146; 1969, Nos, 44, 107 and 185; and 1970, Nos. 39, 94, 119 and 186.
11874/71—Price 30c 10/18.3.1971
First Schedule—continued
8. Amodiaquine Hydrochloride
9. Amphetamine Sulphate
10. Amphetamine Sulphate Tablets
11. Amylobarbitone Sodium Tablets
12. Antazoline Hydrochloride
12a. Antazoline Tablets
13. Antimony Sodium Tartrate
14. Antimony Sodium Tartrate Injection
15. Apomorphine Hydrochloride
16. Apomorphine Injection
16a. Arachis Oil
17. Aspirin Phenacetin and Codeine Tablets
18. Aspirin Phenacetin and Codeine Tablets Soluble
18a. Azathioprine
19. Bacillus Calmette-Guérin Vaccine
20. Barium Sulphate
20a. Beclomethasone Dipropionate
21. Belladonna Herb
22. Belladonna Herb, Powdered
23. Bemegride
23a. Bendrofluazide
23aa. Bemegride Injection
24. Benzhexol Hydrochloride
25. Benztropine Mesylate
26. Betamethasone Sodium Phosphate Tablets
26a. Bethanidine Sulphate
27. Bisacodyl
28. Bisacodyl Suppositories
29. Bisacodyl Tablets
30. Botulinum Antitoxin
30a. Bupivacaine Hydrochloride
31. Busulphan
32. Butobarbitone
33. Butylated Hydroxyanisole
34. Butylated Hydroxytoluene
35. Caffeine Hydrate
36. Calciferol Solution
37. Calcium Cyclamate
37a. Camphor
38. Caramiphen Hydrochloride
39. Caramiphen Tablets
40. Caraway
41. Carbimazole
42. Carbon Dioxide
43. Carbromal Tablets
44. Cardamom Fruit
45. Cascara
47. Catgut, Sterilised, Surgical
48. Cellulose, Oxidised
49. Cetylpyridinium Chloride
50. Chlorambucil
51. Chlordiazepoxide Capsules
52. Chlordiazepoxide Hydrochloride
52a. Chloroform
52b. Chlormadinone Acetate
53. Chloroquine Phosphate
54. Chloroquine Phosphate Injection
55. Chloroquine Sulphate
56. Chlorothiazide
57. Chlorotrianisene
58. Chlorotrianisene Capsules
59. Chlorphenesin
60. Chlorproguanil Hydrochloride
61. Chlorproguanil Tablets
62. Chlorpropamide
62a. Chloretracycline Hydrochloride
63. Chlorthalidone
65. Choline Theophyllinate Tablets
66. Cinchocaine Hydrochloride
67. Cinnamon
67a. Clofibrate
69. Cochineal
70. Colchicine
71. Colchicum Corm
72. Colchicum Liquid Extract
73. Colistin Tablets
73a. Concentrated Peppermint Water
74. Coriander
75. Coriander Oil
76. Corticotropin
76a. Cottonseed Oil
76aa. Corticotropin Injection
76ab. Corticotropin Gelatin Injection
76ac. Corticotropin Zinc Hydroxide Injection
77. Cresol and Soap Solution
78. Cresol
79. Crotamiton
80. Cyanocobalamin
81. Cyanocobalamin (57Co)
82. Cyanocobalamin (58Co)
83. Cyclamic Acid
84. Cyclizine Tablets
85. Cyclobarbitone Calcium
86. Cyclomethycaine Sulphate
81. Cyclopenthiazide
88. Cyclopentolate Hydrochloride
89. Cyclopropane
90. Cycloserine
91. Dapsone
92. Dequalinium Acetate
93. Dequalinium Chloride
94. Desipramine Hydrochloride
96. Dexamphetamine Sulphate
97. Dexamphetamine Tablets
98. Dextran 110 Injection
99. Dextromethorphan Hydrobromide
100. Dextromethorphan Tablets
101. Dextropropoxyphene Capsules
102. Dextropropoxyphene Hydrochloride
103. Dextropropoxyphene Napsylate
103b. Dextrose Monohydrate
104. Diamorphine Hydrochloride
105. Diamorphine Injection
105a. Diazepam Capsules
106. Dibromopropamidine Isethionate
107. Dichloralphenazone
108. Dichlorophen
109. Dichlorphenamide
110. Dicthylcarbamazine Citrate
111. Dicthylcarbamazine Tablets
112. Digitalis Leaf
113. Digitalis Prepared
114. Digitoxin
114a. Digitoxin Tablets
114b. Dihydrocodeine Injection
114c. Dihydrocodeine Tablets
115. Diloxanide Furoate
115a. Dilute Alcohols
116. Dimenhydrinate
117. Dimenhydrinate Injection
118. Dimenhydrinate Tablets
119. Dimercaprol
120. Dimethisterone
121. Dimethisterone Tablets
122. Diodone Injection
123. Diphtheria and Pertussis Vaccine
First Schedule—continued
124. Diptheria, Tetanus and Poliomyelitis Vaccine
125. Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine
126. Dipipanone Hydrochloride
127. Dipipanone Injection
128. Dodecyl Gallate
129. Domiphen Bromide
129a. Dried Human Albumin
330. Dusting Powder Absorbable
131. Edrophonium Chloride
131a. Eltor Vaccine
132. Emetine and Bismuth Iodide
133. Emetine Hydrochloride
134. Erythromycin
134a. Ethacrynic Acid
135. Ethchlorvynol
135a. Ether Anaesthetic
136. Ethinyloestradiol
137. Ethionamide
138. Ethisterone
139. Ethopropazine Hydrochloride
140. Ethotoin
141. Ethyl Chloride
142. Ethyl Oleate
143. Ethylenediamine Hydrate
143A. Eucalyptus Oil
143b. Ethynodiol Diacetate
144. Eugenol
145. Ferric Citrate (59Fe) Injection
146. Ferrous Fumarate
147. Ferrous Succinate Tablets
148. Fludrocortisone Acetate
150. Fluoxymesterone
151. Gallamine Triethiodide
152. Gallamine Injection
153. Gamma Benzene Hexachloride
154. Gelatin Sponge, Absorbable
155. Gentian
156. Ginger
157. Gold (193Au) Injection
159. Halothane
160. Helium
161. Heparin
161a. Hexachlorophane
162. Hexylresorcinol
163. Histamine Acid Phosphate
164. Histamine Acid Phosphate Injection
164a. Human Albumin
165. Human Blood, Whole
166. Human Red Blood, Corpuscles, Concentrated
167. Human Fibrin Foam
168. Human Fibrinogen
169. Human Normal Gamma Globulin Injection
170. Human Plasma, Dried
171. Human Plasma Protein Fraction
172. Human Plasma Protein Fraction, Dried
173. Human Serum, Dried
174. Human Thrombin
175. Hydrochlorothiazide
177. Hydrocortisone Hydrogen Succinate
178. Hydrocortisone Sodium Succinate
179. Hydroflumethiazide
180. Hydrogen Peroxide Solution, Strong
181. Hydroxocobalamin
182. Hydroxychloroquine Sulphate
183. Hyoscine Injection
184. Hyoscine Eye Ointment
184a. Hyoscine Tablets
185. Hyoscyamus
186. Hyoscyamus Dry Extract
187. Indigo Carmine
187a. Influenza Vaccine
187aa. Industrial Methylated Spirit
187b. Inulin
187c. Inulin Injection
188. lodinated (131I) Human Serum Albumin Injection
189. Iodipamide Meglumine Injection
190. Iodised Oil Fluid Injection
191. Iopanoic Acid
192. Iopanoic Acid Tablets
193. Iophendylate Injection
194. Iothalamic Acid
195. Ipecacuanha, Prepared
196. Isocarboxazid
197. Isocarboxazid Tablets
198. Isoniazid
199. Isopropyl Alcohol
199a. Laevulose
201. Lemon Peel, Dried
202. Levallorphan Injection
203. Levorphanol Tartrate
204. Lignocaine and Adrenaline Injection
205. Liothyronine Sodium
206. Liquorice
206a. Lithium Carbonate
206b. Lithium Carbonate Tablets
207. Lucanthone Hydrochloride
208. Lucanthone Tablets
209. Lynoestrenol
210. Magnesium Stearate
210a. Maize Oil
211. Male Fern
212. Maleic Acid
213. Measles Vaccine (Inactivated)
214. Measles Vaccine (Live Attenuated)
215. Mecamylamine Hydrochloride
215a. Mefenamic Acid
215b. Mefenamic Acid Capsules
215c. Metrestrol Acetate
216. Meglumine Iothalamate Injection
217. Melarsoprol
218. Melarsoprol Injection
219. Mepacrine Hydrochloride
220. Mephentermine Sulphate
221. Meprobamate
222. Meprobamate Tablets
222a. Mepyramine Maleate
222b. Mepyramine Tablets
223. Mercaptopurine
224. Mersalyl Acid
225. Mestranol
226. Metaraminol Tartrate
227. Methadone Hydrochloride
228. Methandienone
229. Methicillin Sodium
230. Methohexitone Injection
231. Methoin
232. Methoserpidine
233. Methoserpidine Tablets
234. Methoxyflurane
235. Methyl Hydroxybenzoate
236. Methylamphetamine Hydrochloride
237. Methylamphetamine Injection
238. Methylamphetamine Tablets
239. Methyldopa
First Schedule—continued
240. Methylergometrine Maleate
240a. Methylprednisoione Tablets
241. Methylthiouracil
242. Methylthiouracil Tablets
243. Methyprylone
244. Methyprylone Tablets
245. Metronidazole
246. Nalorphine Hydrobromide
247. Nandrolone Decanoate
248. Nandrolone Phenylpropionate
249. Naphazoline Hydrochloride
250. Nealbarbitone
251. Nealbarbitone Tablets
252. Neostigmine Bromide
253. Nialamide
254. Nialamide Tablets
255. Niclosamide
256. Nicotinic Acid
257. Nicoumalone
258. Nikethamide
259. Nikethamide Injection
260. Nitrous Oxide
261. Norethandrolone
262. Norethandrolone Tablets
263. Norethisterone
266. Norethynodrel
267. Noscapine
268. Novobiocin Calcium
269. Novobiocin Sodium
270. Novobiocin Tablets
271. Nux Vomica
272. Oetyl Gallate
273. Oestradiol Benzoate
273a. Olive Oil
274. Opium
275. Opium, Powdered
276. Orange Peel, Dried Bitter
277. Orphenadrine Hydrochloride
278. Oxygen
279. Oxyphenbutazone
280. Oxyphenbutazone Tablets
281. Oxyphencyclimine Hydrochloride
282. Oxytetracycline Tablets
283. Oxytocin Tablets
284. Paramethadione
285. Paramomycin Capsules
286. Paramomycin Sulphate
287. Pempidine Tartrate
287a. Penicillamine
288. Penicillamine Hydrochloride
289. Pentamidine Isethionate
290. Pentamidine Injection
291. Pentolinium Tartrate Tablets
291a. Peppermint Oil
292. Percutaneous Bacillus Calmette-Guérin Vaccine
293. Perphenazine
294. Perphenazine Tablets
295. Pethidine Tablets
296. Phenacetin
296a. Phenazocine Hydrobromide
296b. Phenazocine Injection
296c. Phenazocine Tablets
297. Phenelzine Sulphate
298. Phenelzine Tablets
299. Phenindamine Tartrate
300. Phenindione
301. Phenmetrazine Hydrochloride
302. Phenmetrazine Tablets
303. Phenolphthalein Tablets
304. Phenolsulphonphthalein
304a. Phenoxybenzamine Capsules
305. Phenoxybenzamine Hydrochloride
306. Phenoxymethylpenicillin
306a. Phenoxymethylpenicillin Potassium
307. Phentolamine Mesylate
308. Phentolamine Injection
310. Phytomenadione Capsules
311. Phytomenadione Tablets
312. Piperazine Citrate
313. Piperazine Phosphate Tablets
314. Poldine Methylsulphate
315. Poldine Tablets
316. Poliomyelitis Vaccine (Inactivated)
317. Poliomyelitis Vaccine (Oral)
317a. Potassium Bromide
318. Potassium Chloride Injection
319. Prednisolone Sodium Phosphate Injection
320. Prednisolone Pivalate Injection
322. Prednisone Acetate
323. Primaquine Phosphate
324. Probenecid
325. Procainamide Tablets
326. Procaine and Adrenaline Injection
327. Prochlorperazine Maleate
328. Prochlorperazine Mesylate
330. Procyclidine Hydrochloride
331. Progesterone
332. Proguanil Hydrochloride
333. Promazine Hydrochloride
334. Promazine Injection
335. Promazine Tablets
336. Promethazine Theoclate
337. Promethazine Theoclate Tablets
338. Propranolol Hydrochloride
339. Propyl Gallate
340. Propyliodone
341. Propyliodone Injection
342. Propyliodone Oily Injection
343. Propylthiouracil
344. Pyrazinamide
345. Pyridostigmine Bromide
346. Pyrimethamine
347. Pyroxylin
348. Quillaia
349. Quinine Dihydrochloride Injection
350. Rabies Antiserum
351. Rabies Vaccine
352. Sesame Oil
353. Soda Lime
354. Sodium Acetate
355. Sodium Acetrizoate Injection
357. Sodium Antimonylgluconate
358. Sodium Antimonylglnconate Injection
359. Sodium Aurothiomalate
360. Sodium Bicarbonate Compound Tablets
361. Sodium Bromide
362. Sodium Calciumedetate
363. Sodium Chromate (51Cr) Solution
364. Sodium Citrate Tablets
365. Sodium Cyclamate
366. Sodium Diatrizoate
367. Sodium Diatrizoate Injection
368. Sodium Fluoride
369. Sodium Fusidale Capsules
370. Sodium Iodide (131I) Injection
370a. Sodium Iodide (125I) Solution
First Schedule—continued
371. Sodium Iodide (131I) Solution
372. Sodium Iodohippurate (131I) Injection
373. Sodium Iothalamate Injection
374. Sodium Lauryl Sulphate
375. Sodium Phosphate (32P) Injection
376. Sodium Stibogluconate
377. Sodium Stibogluconate Injection
378. Solapsone
379. Solapsone Tablets
380. Spironolactone
381. Staphylococcus Antitoxin
382. Stibophen
383. Stibophen Injection
384. Stramonium
385. Sulphadiazine Sodium
386. Sulphadimethoxine
386a. Sulphadimidine Injection
387. Sulphadimidine Sodium
388. Sulphamethizole
389. Sulphamethoxydiazine
390. Sulphamethoxypridazine
391. Sulphapyridine
392. Sulphinpyrazone
393. Sulphobromophthalein Sodium
393a. Sulphomyxin Injection
394. Sulphomyxin Sodium
395. Sulthiame
396. Suramin
397. Suramin Injection
398. Suxamethonium Chloride
399. Testosterone
401. Testosterone Phenylpropionate Injection
403. Tetanus and Pertussis Vaccine
404. Tetanus Vaccine (Alum Precipitated)
405. Tetanus Vaccine (Simple Solution)
406. Tetrachlorocthylene
407. Tetrachloroethylene Capsules
407a. Tetracycline Tablets
408. Thiomersal
409. Thiopentone Sodium
410. Thiopentone Injection
411. Thioridazine Hydrochloride
412. Thyroid
413. Thyroxine Sodium
413a. Tolnaftate
414. Tolazoline Hydrochloride
414a. Tolazoline Tablets
415. Tolbutamide
416. Tranylcypromine Sulphate
417. Tranylcypromine Tablets
419. Triamterene Capsules
420. Trichloroethylene
421. Tricyclamol Chloride
422. Tryparsamide
423. Tryparsamide Injection
424. Tuberculin, Old
425. Tuberculin Purified Protein Derivative
426. Tubocurarine Chloride
427. Tubocurarine Injection
427a. Turpentine Oil
428. Typhoid-Paratyphoid A and B
429. Typhoid-Paratyphoid A and B and Cholera Vaccine
430. Typhoid-Paratyphoid A and B and Tetanus Vaccine
431. Typhoid-Paratyphoid A, B and C Vaccine
432. Undccenoic Acid
433. Urea
434. Urea Injection
435. Vancomycin Hydrochloride
436. Vancomycin Injection
437. Vinyl Ether
438. Vitamin A Ester Concentrate
439. Yellow Fever Vaccine
440. Zinc Undecenoate
441. Zinc Undecenoale Ointment
SECOND SCHEDULE Regulation 10 (3.)
Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations
First Column | Second Column | Third Column |
Item | Pharmaceutical Benefit | Allowable Compounds (if any) |
1 | Acepifylline ........... | — |
2 | Acetylsulphafurazole ..... | — |
3 | Acetylcysteine .......... | — |
4 | Acrylic Resin .......... | — |
5 | Adrenaline Hydrochloride .. | — |
6 | Albumaid XP .......... | — |
7 | Aluminium Sodium Silicate . | — |
8 | Amino Acids ........... | Amino Acids with Sorbitol |
|
| Amino Acids with Sorbitol and Alcohol |
9 | Amphotericin B ......... | Tetracycline, B.P.C. with buffering agent and Amphotericin B |
10 | Ampicillin ............ | — |
11 | Ampicillin Trihydrate ..... | — |
12 | Antazoline Sulphate ...... | Naphazoline Nitrate with Antazoline Sulphate |
Second Schedule—continued
First Column | Second Column | Third Column |
Item | Pharmaceutical Benefit | Allowable Compounds (if any) |
13 | Ascorbic Acid........... | Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Vitamin D and Ascorbic Acid |
|
| Ferrous Sulphate mixture and Ferrous Sulphate mixture C.F. of the Australian Pharmaceutical Formulary |
|
| Ferrous Sulphate mixture Prescribers List |
|
| Ferrous Sulphate mixture Prescribers List Children's Section |
14 | Attapulgite ............. | Dihydrostreptomycin Sulphate with Pectin, Dried Aluminium Hydroxide Gel and Attapulgite |
15 | Bacitracin .............. | Neomycin Sulphate with Polymyxin B Sulphate and Bacitracin |
16 | Bacitracin Zinc .......... | Neomycin Undecenoate with Bacitracin Zinc |
|
| Polymyxin B Sulphate with Neomycin Sulphate and Bacitracin Zinc |
17 | Belladonna Herb, Prepared ... | Phenobarbitone with Belladonna Herb, Prepared |
18 | Belladonna, Dry Extract .... | Phenolphthalein with Aloin, Strychnine, B.P.C. 1959, Ipecacuanha and Dry Extract of Belladonna |
19 | Betamethasone ........... | Betamethasone Acetate with Betamethasone |
20 | Betamethasone Acetate ..... | Betamethasone with Betamethasone Acetate |
21 | Betamethasone Sodium Phosphate | — |
22 | Betamethasone Phosphate ... | — |
23 | Betamethasone Valerate .... | Clioquinol with Betamethasone Valerate |
24 | Brompheniramine Maleate ... | — |
25 | Buclosamide ............ | Salicylic Acid with Buclosamide Salicylic Acid with Hydrocortisone Acetate and Buclosamide |
26 | Calciferol .............. | — |
27 | Calcium Di-Oxytetracycline .. | — |
28 | Capsicum Olcoresin ....... | Cascara Dry Extract with Phenolphthalein, Sodium Tauroglycocholate, B.P.C. 1954 and Capsicum Oleoresin |
29 | Carbachol .............. | Hypromellose 4500 with Carbachol |
31 | Carbinoxamine Maleate ..... | — |
32 | Carbromal .............. | Carbromal with Pentobarbitone Sodium |
33 | Cascara Dry Extract ....... | Phenolphthalein with Capsicum Oleoresin, Sodium Tauroglycocholate, B.P.C. 1954 and Cascara Dry Extract |
34 | Chloramine, B.P.C. ........ | — |
35 | Chloramphenicol ......... | Polymyxin B Sulphate with Chloramphenicol |
|
| Hydrocortisone Acetate with Chloramphenicol |
36 | Chloramphenicol Palmitate, B.P.C. | — |
37 | Chloramphenicol Stearate ... | — |
38 | Chlorhexidine Gluconate .... | — |
40 | Chlorpheniramine Maleate ... | — |
41 | Chlorpromazine Hydrochloride | — |
42 | Chlortetracycline Hydrochloride | — |
43 | Choline Theophyllinate ..... | Guaiphenesin with Choline Theophyllinate |
44 | Clemizole Tannate ........ | — |
45 | Clioquinol .............. | Betamethasone Valerate with Clioquinol |
|
| Flumethasone Pivalate with Clioquinol |
46 | Colistin Sulphate ......... | Neomycin Sulphate with Colistin Sulphate |
47 | Cortisone Acetate ......... | — |
48 | Cyclizine Hydrochloride .... | Ergotamine Tartrate with Caffeine and Cyclizine Hydrochloride |
49 | Cymogran .............. | — |
50 | Cyproheptadine Hydrochloride | — |
51 | Danthron .............. | Dioctyl Sodium Sulphosuccinate, B.P.C. with Danthron |
52 | Demecarium Bromide ...... | — |
53 | Demethylchlortetracycline Hydrochloride | Nystatin with Demethylchlortetracycline Hydrochloride |
54 | Dexamethasone .......... | Framycetin Sulphate with Gramicidin and Dexamethasone |
Second Schedule—continued
First Column | Second Column | Third Column |
Item | Pharmaceutical Benefit | Allowable Compounds (if any) |
55 | Dexamethasone Metasulphobenzoate | Framycetin Sulphate with Gramicidin and Dexamethasone Metasulphobenzoate |
56 | Dexchlorpheniramine Maleate.... | — |
57 | Dextrans .................. | Dextrose with Dextrans |
|
| Sodium Chloride with Dextrans |
58 | Diazepam ................. | — |
59 | Dichloralphenazone ........... | — |
60 | Dicyclomine Hydrochloride ..... | Doxylamine Succinate with Pyridoxine Hydrochloride and Dicyclomine Hydrochloride |
61 | Dienoestrol ................ | — |
62 | Diethanolamine Fusidate ....... | — |
63 | Digoxin ................... | — |
63a | Dihydrocodeine Acid Tartrate | — |
64 | Dihydrostreptomycin Sulphate, B.P. 1958 | Attapulgite with Pectin, Dried Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958 |
|
| Kaolin with Pectin, Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958 |
65 | Dihydrotachysterol ........... | — |
66 | Dimethiconc, B.P.C. .......... | — |
67 | Dioctyl Sodium Sulphosuccinatc, B.P.C | Danthron with Dioctyl Sodium Sulphosuccinate, B.P.C. |
|
| Oxyphenisatin Acetate with Dioctyl Sodium Sulphosuccinatc B.P.C. |
68 | Diphenhydramine Hydrochloride | Ergotamine Tartrate with Caffeine Citrate and Diphenhydramine Hydrochloride |
69 | Diphenylpyraline Hydrochloride | — |
70 | Diphtheria Vaccine ........... | Diphtheria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) |
|
| Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine |
71 | Doxycycline Hyclate .......... | — |
72 | Doxylamine Succinate ......... | Dicyclomine Hydrochloride with Pyridoxine Hydrochloride and Doxylamine Succinate |
73 | Ecothiopate Iodide ........... | — |
75 | Ergometrine Maleate .......... | Oxytocin with Ergometrine Maleate |
76 | Ergotamine Tartrate ........... | Caffeine with Ergotamine Tartrate |
|
| Caffeine with Cyclizine Hydrochloride and Ergotamine Tartrate |
|
| Caffeine Citrate with Diphenhydramine Hydrochloride and Ergotamine Tartrate |
|
| Caffeine with Meclozine Hydrochloride and Ergotamine Tartrate |
77 | Erythromycin Estolate ......... | — |
78 | Erythromycin Stearate ......... | — |
79 | Ethosuximide ............... | — |
80 | Ferric Hydroxide ............. | — |
81 | Ferrous Aminoacetosulphate ..... | — |
82 | Ferrous Succinate ............ | __ |
83 | Flumethasone Pivalate ......... | Clioquinol with Flumethasone Pivalate |
84 | Fluphenazine Hydrochloride ..... | — |
85 | Framycetin Sulphate .......... | Eight Kaolin with Framycetin Sulphate |
|
| Dexamethasone with Framycetin Sulphate and Gramicidin |
|
| Gramicidin and Dexamethasone Metasulphobenzoate with Framycctin Sulphate |
86 | Galactomin, Formula No. 17 | — |
87 | Galactomin, Formula No. 19 | — |
88 | Glucose Indicator, Urine ........ | — |
89 | Goat's Milk, Dehydrated ........ | — |
90 | Goat's Milk ................ | — |
91 | Gramicidin ................ | Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin |
Second Schedule—continued
First Column | Second Column | Third Column |
Item | Pharmaceutical Benefit | Allowable Compounds (if any) |
91—cont. |
| Neomycin Sulphate with Thonzonium Bromide, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Gramicidin |
|
| Framycetin Sulphate with Dexamethasone and Gramicidin |
|
| Framycetin Sulphate with Dexamethasone Metasulphobenzoate and Gramicidin |
|
| Neomycin Sulphate with Nystatin, Triamcinolone Acetonide and Gramicidin |
92 | Guaiphenesin, B.P.C. ...... | Theophylline with Guaiphenesin, B.P.C. |
93 | Glucose Indicator, Blood .... | — |
95 | Hydrocortisone .......... | Polymyxin B Sulphate with Neomycin Sulphate and Hydrocortisone |
|
| 1, 2–Propanediol Diacetate, Acetic Acid, Propylene Glycol and Hydrocortisone |
|
| Neomycin Sulphate with Hydrocortisone |
|
| Natamycin with Neomycin Sulphate and Hydrocortisone |
96 | Hydrocortisone Acetate .... | Buclosamide with Salicylic Acid and Hydrocortisone Acetate |
|
| Neomycin Sulphate with Hydrocortisone Acetate |
|
| Neomycin Sulphate with Gramicidin, Thonzonium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate |
|
| Oxytetracycline Hydrochloride with Hydrocortisone Acetate |
|
| Chloramphenicol with Hydrocortisone Acetate |
98 | Hyoscine Hydrobromide .... | Hypromellose 4500 with Hyoscine Hydrobromide |
|
| Papaveretum with Hyoscine Hydrobromide |
|
| Pethidine Hydrochloride with Hyoscine Hydrobromide |
|
| Morphine Sulphate with Hyoscine Hydrobromide |
99 | Idoxuridine ............. | — |
100 | Ipecacuanha ............ | Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine, B.P.C. 1959 and Ipecacuanha |
101 | Isoniazid .............. | Sodium Aminosalicylate with Isoniazid |
102 | Isoprenaline Hydrochloride .. | — |
103 | Kanamycin Sulphate, B.P.C. . | — |
105 | Lauryl Dimethylbenzyl Ammonium Chloride | 'TERTC' N8 with Lauryl Dimethylbenzyl Ammonium Chloride |
106 | Levallorphan Tartrate ...... | Pethidine Hydrochloride with Levallorphan Tartrate |
107 | Lignocaine Hydrochloride ... | Polymyxin B Sulphate with Propylene Glycol and Lignocaine Hydrochloride |
108 | Lincomycin Hydrochloride .. | — |
109 | Lofenalac .............. | — |
110 | Lypressin .............. | — |
111 | Magnesium Aluminium Hydroxide | — |
112 | Magnesium Chloride ...... | Sodium Chloride with Ammonium Chloride, Potassium Chloride and Magnesium Chloride |
|
| Sodium Chloride with Potassium Chloride, Sodium Lactate and Magnesium Chloride |
113 | Magnesium Hydroxide, B.P.C. | Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. |
|
| Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine |
|
| Aluminium Hydroxide Gel Dried with Magnesium Hydroxide, B.P.C. |
|
| Aluminium Hydroxide Gel Dried with Magnesium Trisilicate and Magnesium Hydroxide, B.P.C. |
114 | Mebhydrolin Napadisylate, B.P.C. | — |
114a | Meclastine Hydrogen Fumarate | — |
115 | Meclozine Hydrochloride ... | Ergotamine Tartrate with Caffeine and Meclozine Hydrochloride |
Second Schedule—continued
First Column | Second Column | Third Column |
Item | Pharmaceutical Benefit | Allowable Compounds (if any) |
116 | Meglumine ............ | Theophylline with Meglumine |
118 | Methacycline .......... | — |
119 | Methdilazine Hydrochloride . | — |
120 | Methenamine Mandelate ... | — |
121 | Minafen .............. | — |
122 | Morphine Tartrate ....... | Morphine Tartrate with Tacrine |
123 | Nalidixic Acid, B.P.C. .... | — |
124 | Naphazoline Nitrate ...... | Naphazoline Nitrate with Antazoline Sulphate |
125 | Natamycin ............ | Neomycin Sulphate with Hydrocortisone and Natamycin |
126 | Neomycin Sulphate ...... | Hydrocortisone Acetate with Neomycin Sulphate |
|
| Hydrocortisone with Neomycin Sulphate |
|
| Colistin Sulphate with Neomycin Sulphate |
|
| Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate |
|
| Kaolin with Neomycin Sulphate |
|
| Polymyxin B Sulphate with Gramicidin and Neomycin Sulphate |
|
| Polymyxin B Sulphate with Hydrocortisone and Neomycin Sulphate |
|
| Prednisolone Sodium Phosphate with Neomycin Sulphate |
|
| Bacitracin with Polymyxin B Sulphate and Neomycin Sulphate |
|
| Thonzonium Bromide with Thonzylamine Hydrochloride, Hydrocortisone Acetate, Gramicidin and Neomycin Sulphate |
|
| Gramicidin with Nystatin, Triamcinolone Acetonide and Neomycin Sulphate |
|
| Natamycin with Hydrocortisone and Neomycin Sulphate |
127 | Neomycin Undecenoate .... | Bacitracin Zinc with Neomycin Undecenoate |
128 | Neostigmine Methylsulphate | — |
129 | Nicotinamide .......... | Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D |
130 | Nitrofurantoin .......... | — |
131 | Noradrenaline Acid Tartrate . | — |
132 | Nortriptyline Hydrochloride . | — |
133 | Nystatin .............. | Tetracycline, B.P.C. with a buffering agent and Nystatin |
|
| Demethylchlortetracyline with Nystatin |
|
| Tetracyline Hydrochloride with Nystatin |
|
| Gramicidin with Neomycin Sulphate |
|
| Triamcinolone Acetonide and Nystatin |
|
| Oxytetracycline Dihydrate with Nystatin |
134 | Nutramigen ............ | — |
135 | Octatropine Methylbromide | — |
136 | Orciprenaline Sulphate .... | — |
136a | Oxytetracycline Dihydrate .. | Nystatin with Oxytetracycline Dihydrate |
137 | Oxytetracycline Hydrochloride | Polymyxin B Sulphate with Oxytetracycline Hydrochloride |
|
| Hydrocortisone Acetate with Oxytetracycline Hydrochloride |
137a | Oxyphenisatin Acetate .... | Dioctyl Sodium Sulphosuccinate, B.P.C. with Oxyphenisatin Acetate |
138 | Oxethazaine ........... | Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine |
139 | Oxytocin ............. | Ergometrine Maleate with Oxytocin |
140 | Pancreatin ............. | — |
141 | Pancreatin Enzyme, 4 times U.S.N.F. XII strength | — |
142 | Papaveretum, B.P.C. ...... | Hyoscine Hydrobromide with Papaveretum, B.P.C. |
143 | Penicillin, Benethamine, B.P.C. | Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin |
Second Schedule—continued
First Column | Second Column | |
Item | Pharmaceutical Benefit | Allowable Compounds (if any) |
144 | Penicillin, Benzathine ..... | Procaine Penicillin with Potassium Penicillin and Benzathine Penicillin |
145 | Penicillin, Benzyl ........ | Procaine Penicillin with Benzyl Penicillin |
|
| Streptomycin Sulphate with Benzyl Penicillin |
|
| Procaine Penicillin with Streptomycin Sulphate and Benzyl Penicillin |
146 | Penicillin, Phenoxymethyl (Benzathine, Hydrabamine, or Calcium Salt) | — |
147 | Penicillin, Potassium ..... | Benzathine Penicillin with Procaine Penicillin and Potassium Penicillin |
143 | Penicillin, Procaine ....... | Benethamine Penicillin, B.P.C. with Sodium Penicillin and Procaine Penicillin |
|
| Benzathine Penicillin with Potassium Penicillin and Procaine Penicillin |
|
| Benzyl Penicillin with Procaine Penicillin |
|
| Benzyl Penicillin with Procaine Penicillin and Streptomycin Sulphate |
149 | Penicillin, Sodium ....... | Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin |
149a | Pentobarbitone ......... | Barbitone Sodium with Phenobarbitone Sodium and Pentobarbitone |
150 | Pertussis Vaccine ........ | Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine |
151 | Pethidine Hydrochloride ... | Levallorphan Tartrate with Pethidine Hydrochloride Hyoscine Hydrobromide with Pethidine Hydrochloride |
152 | Phenethicillin Potassium ... | — |
153 | Pheniramine Maleate ..... | — |
154 | Phenytoin, B.P.C. ........ | — |
154a | Pholcodine ............ | — |
155 | Pipenzolate Methobromide . | — |
156 | Pituitary (Posterior Lobe), Powdered, B.P.C. | — |
157 | Plasma Substitute (Polypeptide) |
|
157a | Polyisobutylene ......... | — |
158 | Polymyxin B Sulphate .... | Chloramphenicol with Polymyxin B Sulphate |
|
| Oxytetracycline Hydrochloride with Polymyxin B Sulphate |
|
| Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate |
|
| Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin |
|
| Propylene Glycol with Acetic Acid and Polymyxin B Sulphate |
|
| Neomycin Sulphate with Hydrocortisone and Polymyxin B Sulphate |
|
| Bacitracin with Neomycin Sulphate and Polymyxin B Sulphate |
|
| Lignocaine Hydrochloride with Propylene Glycol and Polymyxin B Sulphate |
159 | Polyvinyl Alcohol ....... | Pilocarpine Nitrate and Polyvinyl Alcohol |
160 | Prednisolone ........... | — |
161 | Prednisolone Acetate ..... | — |
162 | Methylprednisolone ...... | — |
163 | Prednisolone Sodium Hemisulphate | Sulphaethidole with Prednisolone Sodium Hemisulphate |
164 | Prednisolone Sodium Phosphate | Neomycin Sulphate with Prednisolone Sodium Phosphate |
165 | Prednisolone Pivalate ..... | — |
166 | Primidone ............. | — |
167 | Promethazine Hydrochloride | — |
168 | 1,2-Propanediol Diacetate .. | Hydrocortisone with Propylene Glycol, Acetic Acid and 1,2-Propanediol Diacetate |
Second Schedule—continued
First | Second Column | Third Column |
Item | Pharmaceutical Benefit | Allowable Compounds (if any) |
169 | Pyridoxine Hydrochloride .. | Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride |
170 | Prosobee ............. | — |
171 | Riboflavine ............ | Vitamin A with Thiamine Hydrochloride, Nicotinamide, Ascorbic Acid, Vitamin D and Riboflavine |
172 | Senna Fruit ............ | — |
173 | Silver Nitrate, Toughened .. | — |
173a | Similac Isomil .......... | — |
174 | Sobee ............... | — |
174a | Sodium Acid Citrate ...... | — |
175 | Sodium Lactate ......... | Potassium Chloride with Sodium Chloride and Sodium Lactate |
|
| Potassium Chloride with Magnesium Chloride, Sodium Chloride and Sodium Lactate |
|
| Potassium Chloride with Dextrose and Sodium Lactate |
|
| Sodium Chloride with Dextrose and Sodium Lactate |
|
| Sodium Chloride with Sodium Lactate |
176 | Sodium Potassium Tartrate, B.P.C. | Compound Effervescent Powder, B.P.C. |
177 | Sodium Tauroglycocholate, B.P.C. 1954 | Cascara Dry Extract with Phenolphthalein, Capsicum Oleoresin and Sodium Tauroglycocholate, B.P.C. 1954 |
177a | Sorbitol .............. | Amino Acids with Sorbitol |
|
| Amino Acids with Sorbitol and Alcohol |
178 | Soyalac .............. | — |
180 | Strychnine, B.P.C. 1959 ... | Phenolphthalein with Aloin, Dry Extract of Belladonna, Ipecacuanha and Strychnine, B.P.C. 1959 |
181 | Sulphacetamide, B.P.C. .... | Sulphadiazine with Sulphamerazine, B.P. 1958 and Sulphacetamide, B.P.C. |
182 | Sulphaethidole .......... | Prednisolone Sodium Hemisulphate with Sulphaethidole |
183 | Sulphafurazole ......... | — |
185 | Sulphamethizole ........ | — |
186 | Sulphamethoxazole ...... | Trimethoprim with Sulphamethoxazole |
187 | Sulphamerazine, B.P. 1958 . | Sulphadiazine with Sulphathiazole, B.P.C. and Sulphamerazine, B.P. 1958 |
|
| Sulphadiazine with Sulphacetamide, B.P.C. and Sulphamerazine, B.P. 1958 |
|
| Sulphadiazine with Sulphadimidine and Sulphamerazine, B.P. 1958 |
188 | Sulphaphenazole, B.P.C. ... | — |
189 | Sulphathiazole, B.P.C. .... | Sulphadiazine with Sulphamerazine, B.P. 1958 and Sulphathiazole, B.P.C. |
190 | Surgical Cement ........ | — |
191 | Surgical Cement Solvent ... | — |
192 | Tacrine .............. | Morphine Sulphate with Tacrine |
|
| Morphine Tartrate with Tacrine |
193 | 'TERIC' N8 ............ | Lauryl Dimethylbenzyl Ammonium Chloride with 'TERIC' N8 |
193a | Testosterone Decanoate .... | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
193b | Testosterone Isocaproate ... | Testosterone Propionate. B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
193c | Testosterone Phenylpropionate | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
193d | Testosterone Propionate ... | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
Second Schedule—continued
First | Second Column | Third Column |
Item | Pharmaceutical Benefit | Allowable Compounds (if any) |
194 | Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) | Diphtheria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) |
|
| Diphtheria, Pertussis and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) |
195 | Tetracycline, B.P.C. ...... | Tetracycline, B.P.C. with a buffering agent |
|
| Tetracycline, B.P.C. with a buffering agent and Amphotericin B |
|
| Tetracycline, B.P.C. with a buffering agent and Nystatin |
196 | Tetracycline Hydrochloride . | Tetracycline Hydrochloride with Nystatin |
|
| Procaine Hydrochloride with Tetracycline Hydrochloride |
197 | Thiamine Hydrochloride ... | Riboflavine with Nicotinamide, Ascorbic Acid, Vitamin A, Vitamin D and Thiamine Hydrochloride |
198 | Thioridazine ........... | — |
199 | Thiotepa .............. | — |
200 | Thonzonium Bromide ..... | Neomycin Sulphate with Gramicidin, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Thonzonium Bromide |
201 | Thonzylamine Hydrochloride | Neomycin Sulphate with Gramicidin, Hydrocortisone Acetate, Thonzonium Bromide and Thonzylamine Hydrochloride |
201a | Ticmonium Iodide ....... | — |
202 | Tragacanth, Indian (Gum Karaya) | — |
203 | Triacetyloleandomycin | — |
203a | Triamcinolone Acetonide ... | Gramicidin with Neomycin Sulphate, Nystatin and Triamcinolone Acetonide |
204 | Triclofos Sodium ........ | — |
205 | Trifluoperazine Hydrochloride | — |
206 | Triglyde .............. | — |
207 | Trimeprazine Tartrate, B.P.C. | — |
207a | Trimethoprim .......... | Trimethoprim with Sulphamethoxazole |
208 | Triprolidine Hydrochloride . | — |
209 | Vinyl Acetate .......... | Vinyl Pyrrolidone and Vinyl Acetate with Benzocaine |
209a | Vinyl Pyrrolidone ....... | Vinyl Acetate and Vinyl Pyrrolidone with Benzocaine |
210 | Viprynium Embonate ..... | — |
211 | Vitamin A ............ | Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin D and Vitamin A |
212 | Vitamin D ............ | Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin A and Vitamin D |
THIRD SCHEDULE Regulation 11.
Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia
1. Acepifylline
2. Acetazolamide Sodium
3. Acetohexamide
4. Acetylcholine Chloride
5. Acetylcysteine
6. Acetyl Sulphafurazole
7. Acidified Golden Syrup, A.P.F. 1955
8. Acriflavine, B.P.C. 1963
9. Acrylic Resin
10. Adrenaline Hydrochloride
11. Adrenaline Mucate
12. Agar, B.P.C. 1954
13. Albumaid XP
14. Aldosterone
16. Aloin, B.P.C.
17. Almond Oil Volatile Bitter, B.P.C. 1959
18. Aloxiprin
18a. Alprenolol Hydrochloride
19. Aluminium Acetate Solution, B.P.C.
20. Aluminium Hydroxide Mixture, A.P.F.
Third Schedule—continued
21. Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex
22. Aluminium Sodium Silicate
22a. Amantadine Hydrochloride
23. Amaranth Solution, A.P.F.
24. Amaranth Solution, Compound, A.P.F.
25. Amaranth Solution, B.P.C.
25a. Ambenonium Chloride
26. Amino Acids
27. Aminocaproic Acid
27a. Aminosalicylic Acid
27b. Amitriptyline Embonate
28. Ammonia Aromatic Spirit, B.P.C.
29. Ammonia Solution, strong, B.P.C.
29a. Ammonium Acetate Solution, strong, B.P.C.
30. Ammonium Bicarbonate, B.P.C.
32. Amphotericin B
33. Angiotensin Amide
34. Antazoline Mesylate, B.P.C.
35. Antazoline Sulphate
36. Anti-Haemophilic Factor of Animal Origin
37. Attapulgite
39. Bacitracin Zinc
41. Beeswax, Yellow, B.P.C.
42. Belladonna Suppository, B.P. 1948
43. Benedict's Solution, A.P.F.
44. Benzalkonium Chloride
45. Benzoin Compound Tincture, B.P.C.
46. Benzoin Tincture, B.P.C.
47. Benzoinated Lard, B.P.C. 1954
49. Bephenium Hydroxynaphthoate, B.P.C.
49a. Betahistine Hydrochloride
50. Betamethasone Acetate
51. Betamethasone Phosphate
53. Black Snake Antivenene
54. Biperiden Hydrochloride
55. Bismuth Subgallate, B.P.C.
57. Brompheniramine Maleate
58. Brown Snake Antivenene
59. Buchu Concentrated Infusion, B.P.C. 1954
60. Buclosamide
61. Butyl Aminobenzoate, B.P. 1953
62. Cade Oil, B.P.C.
63. Caffeine and Sodium Benzoate, B.P.C. 1954
64. Caffeine Citrate, B.P.C. 1959
65. Cajuput Spirit, B.P. 1948
66. Calcium Di-Oxytetracycline
67. Calcium Gluconogalactogluconate
68. Calcium Phosphate, B.P.C.
69. Calumba, Concentrated Infusion, B.P.1948
70. Calumba Tincture, B.P. 1948
71. Capreomycin Sulphate
72. Capsicum Ointment, B.P.C.
72a. Capsicum Olcoresin
73. Capsicum Tincture, B.P.C.
74. Carbamazepine
76. Carbenoxolone Sodium
77. Carbinoxamine Maleate
78. Cardamom Aromatic Tincture, B.P.C.
80. Catechu Tincture, B.P.C.
80a. Cephalothin Sodium
81. Cetomacrogol Emulsifying Wax, B.P.C.
82. Charcoal
83. Chloramine, B.P.C.
84. Chloramphenicol Palmitate, B.P.C.
85. Chloramphenicol Stearate
86. Chloramphenicol Succinate
87. Chlorhexidine Acetate
88. Chlorhexidine Gluconate
91a. Cholestyramine
92. Cinnamon Spirit, B.P.C. 1949
94. Clemizole Hydrochloride
95. Clemizole Tannate
97. Clopamide
98. Clorexolone
99. Clove, Concentrated Infusion, B.P.C. 1954
100. Coal Tar, B.P.C.
101. Coal Tar Solution Strong, B.P.C.
102. Cochineal Tincture, B.P. 1948
103. Coconut Oil, B.P.C. 1949
104. Codeine, B.P.C. 1954
105. Copper Sulphate, B.P.C.
106. Creosote, B.P.C. 1959
107. Cudbear Tincture, A.P.F. 1947
108 Cyclothiazide
109. Cycrimine Hydrochloride
110. Cymogran
110a. Cytosine Arabinoside Hydrochloride
111. Danthron
112. Death Adder Antivenene
113. Debrisoquine
114. Demecarium Bromide
116. Deoxycortone Pivalate, B.P. 1963
117. Desferrioxamine Mesylate
118. Deslanoside
119. Dexamethasone Metasulphobenzoate
120. Dexamethasone Sodium Phosphate
121. Dexchlorpheniramine Maleate
122. Dextrans
123. Dextriferron
124. Dibenzepin Hydrochloride
125. Dibutyl Phthalate, B.P. 1963
126. Diathanolamine Fusidate, B.P.C.
127. Diethazine Hydrochloride, B.P. 1963
128. Dihydroergotamine Mesylate
129. Dihvdroergotoxine Mesylate
130. Dihvdrostreptomycin Sulphate, B.P. 1958
131. Dimethicone, B.P.C.
132. Dimethindene Maleate
133. Dioctyl Sodium Sulphosuccinate, B.P.C.
134. Diphenylpyraline Hydrochloride
134a. Diphtheria Vaccine (Purified toxoid aluminium phosphate) diluted
134b. Diphtheria and Tetanus Vaccine, Adult
135a. Disodium Cromoglycate
138. Doxycycline Hyelate
138a. Doxylamine Succinate
138b. Droperidol
141. Ephedrine, B.P.C.
142. Ergot, Liquid Extract, B.P. 1914
143. Erythritvl Tetranitrate
144. Erythromvcin Ethyl Succinate
145. Erythromvcin Glucoheptonate
146. Ervthromvcin Lactobionate
148. Ethanolamine, B.P.C.
149. Ethanolamine Oleate
150. Ether Nitrous Spirit, B.P.C. 1959
151. Ethoxzolamide
Third Schedule—continued
152. Ethylidene Dicoumarin
153. Ethylnoradrenaline Hydrochloride
154. Ethyloestrenol
156. Ferric Hydroxide
157. Ferrous Aminoacetosulphate
158. Ferrous Carbonate Saccharated, B.P.C. 1959
159. Ferrous Phosphate Compound, Syrup B.P.C.
161. Flumethasone Pivalate
162. Fluorouracil Sodium
164. Fluphenazine Enanthate
164a, Flurandrenolone Acetonide
166. Framycetin Sulphate
167. Galactomin, Formula No. 17
168. Galactomin, Formula No. 19
169. Gall and Opium Ointment, B.P.C. 1963
170. Gelsemium Tincture, B.P.C.
171. Gentamicin Sulphate
172. Gentian Concentrated Compound Infusion, B.P. 1963
173. Ginger Syrup, B.P.C.
173a. Glibenclamide
174. Glucagon Hydrochloride
175. Glucose Indicator-Blood
175a. Glucose Indicator-Urine
176. Glycerophosphate Compound Syrup, A.P.F.
177. Glycopyrronium Bromide
178. Glymidine
179. Goat's Milk, Dehydrated
180. Goat's Milk, Whole (Sterilised)
181. Gramicidin
182. Guaiphenesin, B.P.C.
185. Hamamelis Liquid Extract, B.P.C.
186. Hexocyclium Methylsulphate
187. Haemodialysis Fluid—Concentrate
188. Hydrargaphen
189. Hydrocyanic Acid, Dilute.B.P.C.1954
190. Hydromorphone Hydrochloride
191. Hydroxyprogesterone
192. Hyoscine Methobromide
193. Hypophosphorous Acid, Dilute, B.P.C.1963
194. Hypromellose 4500
196. Indomethacin
196a. Influenza Vaccine—Sub Unit type (Desoxycholate Treated)
196b. Injection of Amino Acids with Sorbitol and Alcohol
196c. Injection of Casein Hydrolysate with Laevulose and Alcohol
196e. Injection of Dextran with Dextrose
196F. Injection of Potassium Chloride with Sodium Lactate and Dextrose
196g. Injection of Sodium Chloride with Potassium Chloride, Calcium Chloride and Dextrose
196h. Injection of Sodium Chloride with Sodium Lactate and Dextrose
197. Insect Allergen Extract—Honey Bee
197a. Insect Allergen Extract—Jumper Ant
197b. Insect Allergen Extract—Paper Wasp
198. Insulin Injection, specially purified
199. Insulin Isophane Injection, specially purified
200. Insulin Injection, Special P (Pig)
201. Invert Sugar
202. Iodoform, B.P.C. 1954
203. Ipecacuanha and Opium Powder, B.P.C.
204. Iron Polymaltose Complex
205. Isoprenaline Hydrochloride
206. Isopropainide Iodide
208. Kanamycin Sulphate, B.P.C.
210. Lanatoside-C
211. Lauryl Dimethyl Benzyl Ammonium Chloride
212. Lavender Spike Oil, B.P.C.
213. Lead Subacetate Dilute Solution
214. Lead Subacetate Strong Solution, B.P.C.
214a. Levodopa
214b. Lemon Oil Terpeneless, B.P.C.
215. Lemon Tincture, B.P. 1958
215a. Leucovorin
216. Lincomycin Hydrochloride
217. Lipopancreatin
218. Lobelia Ethereal Tincture, B.P.C.
219. Lofenalac
220. Lypressin
221. Magenta, B.P.C.
222. Magnesium-Aluminium Hydroxide
223. Magnesium Hydroxide, B.P.C.
223a. Maphenide Acetate
223b. Mebeverine Hydrochloride
224. Mebhydrolin Napadisylate, B.P.C.
225. Meclastine Hydrogen Fumarate
226. Medroxyprogesterone Acetate
227. Melphalan
228. Mepenzolate Bromide
229. Mercaptomerin Sodium
230. Mercuric Chloride, B.P.C.
231. Metaraminol Bitartrate
233. Methacycline
234. Methaqualone Hydrochloride
236. Methdilazine Hydrochloride
237. Methenamine Mandelate
238. Methenolone Acetate
240. Methoxamine Hydrochloride, B.P.C.
241. Methsuximide
242. Methyclothiazide
243. Methylphenobarbitone, B.P.C. 1963
244. Methylprednisolone Acetate
244a. Methyprednisolone Sodium Succinate
245. Methysergide Maleate
246. Metyrapone
247. Minafen
248. Morphine Tartrate
249. Myrrh Tincture, B.P.C.
250. Nalidixic Acid, B.P.C.
251. Nandrolone Hexoxyphenyl Propionate
252. Natamycin
253. Neomycin Undecenoate
255. Nitrazepam
256. Nitromin
257. Nutramigen
258. Octatropine Methylbrormide
259. Oestradiol Dipropionale, B.P.C. 1954
260. Oestrone, B.P.C. 1954
26l. Oily Opthalmic Vehicle, A.P.F. 1955
262. Orange Peel Compound Concentrated Infusion, B.P.C. 1954
263. Orange Peel, Concentrated Infusion, B.P.C.
264. Orange Syrup, B.P.C.
265. Orange Tincture, B.P.C.
266. Oxethazaine
Third Schedule—continued
266a. Oxprenolol Hydrochloride
267. Oxycodone Pectinate
268. Oxymel, B.P.O.
269. Oxymel of Squill, B.P.C.
270. Oxymetholone
270a. Oxyphenisatin Acetate
271. Oxyphenenium Bromide
272. Oxytetracycline.
273. Oxytocin
274. Pancreatin Enzyme, U.S.N.F. XII
275. Papaveretum, B.P.C.
277. Paraben Ophthalmic Phosphate Buffer, A.P.P. 1955
278. Paraben Ophthalmic Vehicle, A.P.F.1955
279. Paraffin Liquid Light, B.P.C. 1963
280. Paramethasone Acetate
282. Pectin
283. Penicillinase
284. Penicillin Benethamine, B.P.C.
285. Pentaerythritol Tetranitrate, diluted.B.P.C.
285a. Pentazocine Lactate
286. Penthienate Methobromide
286a. Pentobarbitone
286b. Peritoneal Dialysis Solution with Dextrose
287. Peru Balsam, B.P.C.
288. Phenazone, B.P.C.
290. Phenformin Hydrochloride
291. Pheniramine Maleate
292. Pheniramine Para-Aminosalicylate
293. Phenol Ointment, B.P. 1948
294. Phenoxymethylpenicillin, Benzathine
295. Phenoxymethylpenicillin, Hydrabamine
296. Phensuximide, B.P.C.
297. Phenthimentonium
298. Phenytoin, B.P.C.
299. Phosphoric Acid Dilute, B.P. 1963
300. Phthalylsulphacetamide
301. Physostigmine, B.P.C.
302. Pilocarpine Hydrochloride
303. Pipenzolate Methobromide
304. Pituitary Hormone, Follicle-stimulating, Human
305. Pituitary Hormone, Growth, Human
306. Pituitary (Posterior Lobe) Powdered, B.P.C.
306a. Plasma Substitute (Polypeptide)
306b. Polyisobutylene
307. Polyoestradiol Phosphate
308. Polyvinyl Alcohol
311. Potassium Chlorate, B.P.C.
312. Potassium Effervescent Tablets
313. Potassium Perchlorate
314. Prednisolone Acetate
315. Prednisolone Sodium Succinate
316. Prednisolone Sodium Hemisulphate
317. Prednisolone Tertiary Butyl Acetate
318. Procarbazine Hydrochloride
318a. Prochlorperazine
319. 1,2-Propanediol Diacetate
319a. Proscillaridin
320. Prosobee
321. Protriotyline Hydrochloride
322. Pumilio Pine Oil, B.P.O.
323. Pyridine Aldoxime Methiodide
324. Quillaia Tincture. B.P.C.
325. Quinethazone
326. Quinidine Bisulphate
327. Raspberry Syrup, B.P.C.
328. Rauwolfia Alkaloids
328a. Rauwolfia Serpentina, B.P.C.
329. Red Back Spider Antivenene
330. Rolitetracyeline
331. Rosemary Oil, B.P.C.
332. Salicylamide
333. Secbutobarbitone Sodium
334. Senega, Concentrated Infusion, B.P.C. 1959
335. Senega, Concentrated Infusion, B.P.C. 1963
336. Senna Compound Mixture, B.P.C. 1959
337. Senna. Concentrated Infusion, B.P.C. 1959
338. Senna Fruit Extract (Standardised)
339. Siberian Fir Oil, B.P.C. 1949
340. Silver Protein, B.P.C.
341. Silver Protein Mild, B.P.C.
341a. Similac Isomil
342. Snake Bite Antivenene—Polyvalent
343. Sobee
314. Sodium Folate
345. Sodium Lactate
345a. Sodium Lactate Compound Injection, B.P. with Dextrose
346. Sodium Nitrite, B.P.C.
347. Sodium Nitroprusside
348. Sodium Potassium Tartrate, B.P.C.
349. Sodium Tauroglycocholate, B.P.C. 1954
351. Sorbide Nitrate
352. Sorbitol
353. Soyalac
356. Squill Tincture, B.P.C.
357. Stanolone
358. Stanozolol
359. Stearic Acid, B.P.C.
359a. Stilboestrol Diphosphate
360. Stone Fish Antivenene
360a. Streptokinase
361. Strophanthus Tincture, B.P. 1948
362. Strychnine, B.P.C. 1959
363. Sulphacetamide, B.P.C.
363a. Sulphaethidole
365. Sulphamerazine, B.P. 1958
366. Sulphamethoxazole
367. Sulphaphenazole. B.P.C.
368. Sulphasalazine
368a. Sulphasymazine
360. Sulphathiazole, B.P.C.
170. Sulphurated Potash, B.P.C.
371. Sulphuric Acid, Dilute, B.P.C.
372. Sulphur Sublimed, B.P.C.
373. Surgical Cement
374. Surgical Cement Solvent
376. Syrup Glucose Liquid, B.P.C. 1963
377. Tacrine
378. Taipan Antivenene
379. Tar Ointment. B.P.C. 1959
380. Tartrazine. B.P.C. 1954
381. TERIC N 8
38lA. Testosterone Decanoate
382. Testosterone Enanthate
382a. Testosterone Isocaproate
383. Tetracosactrin
384. Tetraecycline. B.P.C.
384a Thiabendazole
Third Schedule—continued
384b. Thiethylperazine Malate
385. Thiethylperazine Maleate
386. Thioridazine
388. Thonzonium Bromide
389. Thonzylamine Hydrochloride
390. Thyrotrophin
391. Tiemonium Iodide
392. Tiger Snake Antivenene
393. Titanium Dioxide, B.P.C.
394. Tolazamide
395. Tolu Tincture, B.P.C. 1959
396. Tragacanth, Indian (Gum Karaya)
397. Tragacanth Mucilage
399. Tretamine
400. Triacetyloleandomycin
401. Tridehexethyl Chloride
402. Triethanolamine, B.P.C.
403. Triglyde
404. Trimeprazine Tartrate, B.P.C.
405. Trimethoprim
405a. Trimipramine Maleate
405b. Trimipramine Mesylate
406. Trolnitrate Phosphate
407. Typhoid Vaccine
408. Typhoid and Cholera El Tor Combined Vaccine
409. Urethane, B.P. 1963
411. Valerian Ammoniated Tincture, B.P.C.1963
412. Vanillin
413. Vasopressin Tannate
415. Vinblastine Sulphate
416. Vincristine Sulphate
417. Vinegar of Squill, B.P.C.
417a. Vinyl Acetate
417b. Vinyl Pyrrolidone
418. Vitamin A
419. Vitamin D
420. Zinc Gelatin, B.P.C.
FOURTH SCHEDULE
Regulation 12.
Additives
1. Acetone, B.P.C.
2. Alcohol (95%), B.P.
3. Arachis Oil, B.P.
4. Amethocaine Hydrochloride, B.P.
5. Camphor, B.P.
6. Caraway Oil, B.P.C.
7. Carmine Solution, A.P.F.
8. Citronella Oil, B.P.C.
9. Chloroform, B.P.
9a. Concentrated Anise Water, B.P.C.
9b. Concentrated Cinnamon Water, B.P.C
9c. Concentrated Peppermint Water, B.P.
10. Cottonseed Oil, B.P.
12. Dextrose Monohydrate, B.P.
13. Dilute Alcohols, B.P.
14. Ether Anaesthetic, B.P.
14a. Eucalyptol, B.P.C.
14b. Eucalyptus Oil, B.P.
15. Honey–Purified, B.P.C.
16. Maize Oil, B.P.
17. Olive Oil, B.P.
17A. Peppermint Oil, B.P.
20. Sodium Thiosulphate, B.P.C.
21. Solution of Burnt Sugar, B.P.C.1959
22. Spirit, Methylated, Industrial, B.P.
22a. Syrup of Pholcodine Citrate, B.P.C.1959
22b. Turpentine Oil, B.P.
23. Xylene, B.P.C. 1949
FIFTH SCHEDULE Regulation 14.
Pharmaceutical Benefits the Prescribing or Which is Subject to Conditions and Restrictions
First Column | Second Column | |
Item | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
1 | Acetylcysteine.......... | Cystic Fibrosis (mucoviscidosis) |
2 | (1) Aspirin with Paracetamol and Caffeine Tablets | Any disease or condition in a pensioner |
| (2) Aspirin with Codeine Phosphate and Pentobarbitone Sodium Tablets |
|
3 | Acrylic Resin ............ | Ileostomy or colostomy conditions |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
|
|
|
4 | Albumaid XP ........... | With the written authority of the Director-General, Phenylketonuria |
5 | Aldosterone ............ | With the written authority of the Director-General, treatment of an acute crisis in adrenal cortical hypofunction (including Addison's disease and salt-losing congenital adrenal hypoplasia) |
6 | Alprenolol Hydrochloride Injection | Idiopathic hypertrophic subaortic stenosis |
| Right ventricular outflow tract obstruction | |
|
| Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
7 | Alprenolol Hydrochloride Tablets | With the written authority of the Director-General, |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
7A | Amantadine Hydrochloride .. | With the written authority of the Director-General, treatment of Parkinson's disease in conjunction with Levodopa |
8 | Ambenonium Chloride ..... | Myasthenia gravis |
9 | Aminocaproic Acid ....... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
10 | Aminosalicylic Acid ....... | Tuberculosis |
11 | Amphotericin B Injection ... | Systemic mycoses |
13 | (1) Ampicillin Capsules, B.P. . | Infections of the car or respiratory tract where they cannot be safety and effectively treated with sulphonamides, phenoxymethylpenicillin or phenethicillin |
| (2) Ampicillin Injections, Tablets and Suspension |
|
|
| Gram-negative infections where ampicillin appears to be the most suitable drug |
|
| Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to ampicillin or where the patient is sensitive to sulphonamides |
|
| Broad spectrum antibiotic treatment of patients undergoing steroid therapy or recently subjected to steroid therapy |
|
| Bacterial endocarditis |
|
| Meningitis |
|
| Infections in pregnant women or in children where these cannot be safely and effectively treated with sulphonamides, phenoxymethylpenicillin or phenethicillin, excluding infections due to penicillin resistant staphylococci |
14 | Ascorbic Acid Tablets, B.P. .. | Any disease or condition in a pensioner |
15 | Azathioprine ............ | With the written authority of the Director-General, azathioprine therapy for a person who has been discharged from an approved hospital and received that therapy while a patient in the hospital |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
|
|
|
17 | Benzathine Penicillin, B.P. ...... | Prophylaxis of recurrent streptococcal infections (including rheumatic fever) |
18 | Benzoin Compound Tincture, B.P.C. aerosol spray | Ileostomy or colostomy conditions |
19 | Benzylpenicillin Injection, 5,000,000 units | Bacterial endocarditis or septicaemia |
20 | (1) Benzylpenicillin Tablets, B.P. | Prophylaxis of recurrent streptococcal infections, (including rheumatic fever) |
| (2) Benzylpenicillin Capsules |
|
21 | Benzylpenicillin Injection, 10,000,000 units | Bacterial endocarditis or septicaemia |
|
| Gastrointestinal surgery |
22 | (1) Benzylpenicillin with Streptomycin Sulphate | Endocarditis due to streptococcus faccalis or streptococcus viridans |
| (2) Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate |
|
23 | Betahistine Hydrochloride ...... | Meniere's Syndrome |
24 | Betamethasone Acetate and Betamethasone Injection | Intra-articular use |
|
| With the written authority of the Director-General, pre-operative and post-operative prophylactic therapy for those patients undergoing or recently subjected to steroid therapy |
25 | Buclosamide with Salicylic Acid | For the treatment of diseases of the car |
26 | Buclosamide, Salicylic Acid and Hydrocortisene Acetate | For the treatment of diseases of the car |
27 | Busulphan Tablets, B.P. ........ | Treatment in malignant neoplasia |
28 | (1) Calciferol Tablets, Strong, B.P. | Any disease or condition in a pensioner |
| (2) Calciferol, B.P. ........... | With the written authority of the Director-General— |
|
| Hypoparathyroidism |
|
| Osteomalacia following gastrectomy |
|
| Vitamin D-resistant rickets |
29 | Calcium Aminosalicylate ....... | Tuberculosis |
30 | Capreomycin Sulphate ......... | Tuberculosis |
31 | Carbamazepine .............. | Epilepsy |
|
| Trigeminal neuralgia |
32 | Carbenicillin Sodium .......... | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that carbenicillin is the most appropriate therapeutic agent |
33 | Carbenoxolone Sodium ........ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
34 | Cephaloridine .............. | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephaloridine is the most appropriate therapeutic agent |
35 | Cephalothin Sodium .......... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
36 | Charcoal Tablets ............. | Ileostomy or colostomy conditions |
37 | Chlorambucil Tablets, B.P. ...... | Treatment in malignant neoplasia |
38 | Chloramme Deodorant Tablets and Powder | Ileostomy or colostomy conditions |
39 | (1) Chloramphenicol Capsules, B.P. | Bacterial meningitis |
| (2) Chloramphenicol Injections ... | Intraocular infections |
| (3) Chloramphenicol Oral Suspension | Rickettsioses |
|
| Typhoid |
|
| The treatment of other serious infections in a patient where it is established by appropriate bacteriological testing that Chloramphenicol is the only suitable antibiotic listed as a pharmaceutical benefit for use in treating the infection in the patient |
40 | Chlorotrianisene Tablets ........ | Carcinoma of the prostate |
41 | (1) Chloropromazine Hydrochloride, B.P. | Any disease or condition in a pensioner |
| (2) Chlorpromazine Injection, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
|
|
|
41—cont. | (3) Chlorpromazine Tablets, B.P. | The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, B. P., Chlorpromazine Injection, B.P. or Chlorpromazine Tablets, B.P. |
|
| With the written authority of the Director-General— |
|
| Hereditary chorea (Huntington's) |
|
| Malignant neoplasia (Late stage) |
|
| Radiation sickness |
|
| The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
42 | Cholestyramine .......... | With the written authority of the Director-General— |
|
| Bile salt malabsorption associated with ileal resection or proven ileal disease |
|
| Pruritis associated with partial biliary obstruction not responding to other therapy |
|
| Initial treatment with cholestyramine of proven hyperbetalipoproteinaemia (type II) not responding to other therapy |
|
| A second or subsequent course of treatment for proven hyperbetalipoproteinaemia (type II) in patients who respond to treatment with cholestyramine but do not respond to other therapy |
43 | Clofibrate .............. | With the written authority of the Director-General— |
|
| Diabetic retinopathy (exudative) |
|
| Initial treatment with clofibrate of hyperlipidaemia not responding to dietary therapy |
|
| A second or subsequent course of treatment for hyperlipidaemia where significant lowering of serum cholesterol subsequent to inital treatment with clofibrate has been established by laboratory report |
44 | (1) Cloxacillin Sodium, B.P. . | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Cloxacillin Capsules, B.P. |
|
|
| With the written authority of the Director-General, life threatening infection where bacteriological evidence confirms the presence of penicillinase-producing staphylococci |
45 | (1) Codeine Phosphate with Aspirin Soluble Tablets | Any disease or condition in a pensioner |
| (2) Codeine Phosphate with Aspirin Tablets |
|
| (3) Codeine Phosphate with Aspirin and Paracetamol Soluble Tablets |
|
| (4) Codeine Phosphate with Aspirin and Paracetamol Tablets |
|
| (5) Codeine Phosphate with Aspirin, Paracetamol and Caffeine Tablets |
|
47 | Colistin Sulphomethate Sodium, B.P., for injection | Pyocyaneus infection, other gram-negative infections where no other drug is effective |
48 | Cyanocobalamin Injection, B.P. | Pernicious anaemia and other proven Vitamin B-12 deficiencies |
|
| Post gastrectomy treatment |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
|
|
|
48—cont. |
| Sub-acute combined degeneration of the cord |
|
| Neuroblastoma |
49 | (1) Cycloserine Tablets, B.P. .. | Tuberculosis |
| (2) Cycloserine Capsules, B.P. |
|
50 | Cymogran .............. | With the written authority of the Director-General, phenylketonuria |
51 | (1) Cyproheptadine Hydrochloride, B.P. | Allergic rhinitis |
|
| Allergic dermatosis |
| (2) Cyproheptadine Tablets, B.P. | Migraine |
52 | Cytosine Arabinoside Hydrochloride | Any disease or condition in a patient receiving treatment in or at an approved hospital |
53 | Deodorant Detergent Solution (Lauryldimethyl Benzyl Ammonium Chloride and 'TERIC' N8) | Ileostomy or colostomy conditions |
54 | (1) Deoxycortone Acetate Injection, B.P. | Adrenal cortical hypofunction including Addison's disease |
| (2) Deoxycortone Pivalate Injection, B.P. | Total adrenalectomy |
| (3) Deoxycortone Acetate Implants, B.P. |
|
| (4) Deoxycortone Acetate Tablets |
|
55 | Desferrioxamine Mesylate .... | Acute iron poisoning |
|
| Hepatolenticular degeneration |
57 | (1) Dextromoramide Tablets, B.P. | Treatment in malignant neoplasia |
| (2) Dextromoramide Tartrate, B P. |
|
58 | Diazepam Injection ........ | Any disease or condition in a pensioner |
|
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| Electrical conversion of cardiac arrythmias (cardioversion) |
|
| Endoscopy |
|
| Epilepsy |
|
| Minor operative procedures |
|
| Motor neurone lesion |
|
| Premedication induction of anaesthesia |
|
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Diazepam |
|
| With the written authority of the Director-General— |
|
| Hereditary chorea (Huntington's) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
59 | Diazepam Syrup and 10 mg. Tablets | Any disease or condition in a pensioner |
|
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| Epilepsy |
|
| Motor neurone lesion |
|
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Diazepam |
|
| With the written authority of the Director-General— Hereditary chorea (Huntington's) |
Fifth Schedule—continued
First | Second Column | Third Column |
Item | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
|
|
|
59—Cont. |
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
60 | Diazepam Tablets 2 mg, and 5 mg. | Any disease or condition in a pensioner |
|
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| Epilepsy |
|
| Motor neurone lesion |
|
| Multiple sclerosis |
|
| Stiff-man syndrome |
|
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Diazepam |
|
| With the written authority of the Director-General— |
|
| Hereditary chorea (Huntington's) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
61 | Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride | Vomiting in pregnancy |
62 | Dienoestrol Cream ....... | Any disease or condition in a pensioner |
64 | (1) Dihydroergotoxine Mesylate tablets | For the treatment of patients who have suffered an attack of paralytic poliomyelitis |
| (2) Dihydroergotoxine Mesylate injection |
|
65 | Dihydrotachysterol ....... | Hypoparathyroidism |
67 | Dimethicone Aerosol Spray .. | Ileostomy or colostomy conditions |
68 | Dimethicone Creams ...... | Use with surgical appliances |
69 | (1) Dioctyl Sodium Sulphosuccinate with Danthron | Any disease or condition in a pensioner |
| (2) Dioctyl Sodium Sulphosuccinate with Oxyphenisatin Acetate |
|
70 | Disodium Cromoglycate .... | With the written authority of the Director-General— The prevention of attacks of asthma in the case of a patient whose attacks of asthma have been sufficiently severe and frequent to interfere seriously with his normal activities of life and whose recurrences of asthma— |
|
| (a) were not controlled by adequate use of bronchodilators and other recognized methods of prevention and treatment; or |
|
| (b) required the continuous use of corticosteroid therapy |
72 | Droperidol ............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
74 | Ethacrynic Acid ......... | Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome |
|
| Fluid retention associated with other conditions and not responding to thiazides |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
|
|
|
75 | Ethinyloestradiol Tablets, B.P. . | Any disease or condition in a pensioner |
|
| Carcinoma of the breast post-menopausal |
|
| Carcinoma of the prostate |
|
| Hereditary telangiectasis |
|
| Premature menopause that is surgically induced |
|
| Turner's syndrome |
76 | Ethionamide ............ | Tuberculosis |
77 | Ethisterone Tablets, B.P. .... | Turner's syndrome |
78 | Ethyloestrenol ........... | With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long term treatment with corticosteroids |
|
| Osteomalacia following gastrectomy |
79 | Fludrocortisone Tablets, B.P. . | Adrenal cortical hypoplasia including Addison's disease |
|
| Total adrenalectomy |
81 | Fluorouracil Sodium ....... | Treatment in malignant neoplasia |
82 | Fluoxymesteronc Tablets, B.P. | Eunuchism |
|
| Eunuchoidism |
|
| Carcinoma of the breast |
|
| With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Proven aplastic anaemias |
83 | Fluphenazine Enanthate ..... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with either or both of the following pharmaceutical benefits— |
|
| Fluphenazine Enanthate |
|
| Fluphenazine Hydrochloride |
|
| With the written authority of the Director-General— |
|
| Hereditary chorea (Huntington's) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
84 | Fluphenazine Hydrochloride .. | Any disease or condition in a pensioner |
|
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with either or both of the following pharmaceutical benefits— |
|
| Fluphenazine Enanthate |
|
| Fluphenazine Hydrochloride |
|
| With the written authority of the Director-General— |
|
| Hereditary chorea (Huntington's) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| The treatment of a mental disorder in a person who has been discharged from an approved hospital |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
|
|
|
84–cont. |
| at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
85 | (1) Folic Acid, B.P. ......... | Cystic fibrosis |
|
| Proven folic acid deficiency |
| (2) Folic Acid Tablets, B.P. 5 mg. | Sprue or the sprue-like syndrome |
86 | Folic Acid Tabids, B.P. 0.5 mg. | Cystic fibrosis |
|
| Pregnancy |
87 | Framycetin Sulphate Tablets ... | Bowel sterilization preparatory to major surgery |
88 | Frusemide Tablets, B.P. ...... | Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome |
|
| Fluid retention associated with other conditions and not responding to thiazides |
89 | Galactomin Formula No. 17 .... | With the written authority of the Director-General— |
|
| Galactosaemia. |
|
| Conditions needing an extreme restriction of lactose in the diet of a patient under the age of four years |
90 | Galactomin Formula No. 19 .... | With the written authority of the Director-General, glucose-galactose malabsorption |
91 | Gentamicin Sulphate ........ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
92 | Glucose Indicator—Blood ..... | With the written authority of the Director-General, diabetes mellitus, where blood sugar levels cannot be determined to be within a satisfactory range by urine testing |
93 | Goat's Milk, Dehydrated ...... | With the written authority of the Director-General, cow's milk allergy in children under the age of four years |
94 | Goat's Milk, Whole (Sterilized) . | With the written authority of the Director-General, cow's milk allergy in children under the age of four years |
95 | (1) Griseofulvin, B.P. ........ | With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination or Wood's Light |
| (2) Griseofulvin Tablets, B.P. ... | |
97 | Halibut Liver Oil Capsules .... | Any disease or condition in a pensioner |
98 | Haloperidol .............. | Any disease or condition in a pensioner |
|
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| The treatment of a mental disorder in a person who has after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Haloperidol |
|
| With the written authority of the Director-General— |
|
| Hereditary chorea (Huntington's) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
100 | Hydrocortisone Acetate Injection, B.P. | Intra-articular use |
101 | Hydrocortisone Sodium Succinate Injection | Acute adrenal cortical hypofunction due to medical or surgical crisis |
|
| Prophylactic therapy before, during and after surgical procedures for patients undergoing or recently subjected to steroid therapy |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
|
|
|
102 | Hydroxocobalamin Injection, B.P. | Pernicious anaemia and oilier proven Vitamin B-12 deficiencies |
|
| Post gastrectomy treatment |
|
| Sub-acute combined degeneration of the cord |
|
| Neuroblastoma |
103 | Hydroxyprogesterone Caproate ... | Carcinoma of the endometrium |
|
| Progesterone deficiency proved by hormonal assay, by lateral wall smear or by endometrial biopsy |
104 | Idoxuridine ................ | Infections caused by Herpes Simplex Virus |
105 | Influenza Vaccine ............ | For prophylaxis of pensioners only |
106 | Insect Allergen Extract–Honey Bee | With the written authority of the Director-General, score constitutional reaction to bee stings |
106a | Insect Allergen Extract Jumper Ant | With the written authority of the Director-General, severe constitutional reaction to jumper and stings |
107 | Insect Allergen Extract—Paper Wasp | With the written authority of the Director-General, severe constitutional reaction to wasp stings |
108 | Isoniazid Tablets, B.P. | Tuberculosis |
109 | Isoprenaline Hydrochloride Tablets, 30 mg. | Stokes-Adams syndrome |
110 | Kanamycin Sulphate Capsules, Injections and Oral Solution | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the most appropriate antibiotic |
111 | Leucovorin ................ | Antidote to folic acid antagonists |
112 | Levodopa ................. | With the written authority of the Director-General, treatment of Parkinson's disease |
113 | Levorphanol Tartrate .......... | Obstetrical use |
|
| Severe intractable pain |
114 | Lignocaine Injection, B.P. ...... | Cardiac arrhythmias |
115 | Lincomycin Hydrochloride ...... | Gram positive coccal infections where these cannot be safely and effectively treated with a penicillin |
|
| Osteomyelitis |
116 | Liothyronine Tablets, B.P. ...... | Myxoedema |
117 | Lofenalac ................. | With the written authority of the Director-General, phenylketonuria |
118 | Lypressin Nasal Spray ......... | Diabetes insipidus |
119 | Maphenide Acetate ........... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
120 | Medroxyprogesterone Acetate Tablets, 2.5 mg. | Carcinoma of the endometrium |
121 | Medroxyprogesterone Acetate | Carcinoma of the endometrium |
| Tablets, 10 mg. | Precocius puberty |
122 | Medroxyprogesterone Acetate | Carcinoma of the breast |
| Tablets, 100 mg | Carcinoma of the endometrium |
|
| Hypernephroma |
123 | Medroxyprogesterone Acetate | Carcinoma of the endometrium |
| Injections | Hypernephroma |
|
| Progesterone deficiency proven by hormonal assay, by lateral wall smear or by endometrial biopsy |
124 | Melphalan ................. | Treatment in malignant neoplasia |
125 | Mercaptopurine Tablets, B.P. .... | Allergic granulomatous angitis |
|
| Lupus erythematosus |
|
| Nephrotic syndrome |
|
| Periarteritis (Nodosa) |
|
| Treatment in malignant neoplasia |
126 | (1) Methandienone Tablets, B.P. | With the written authority of the Director-General— |
| (2) Methenolone Acetate ....... | Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
127 | Methicillin Sodium, B.P. for Injection | Proven or suspected staphylococcal septicaemia |
128 | Methotrexate Tablets .......... | Treatment in malignant neoplasia |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
|
|
|
129 | Methotrexate Injections ....... | Treatment in malignant neoplasia |
129A | Methylprednisolone Acetate .... | With the written authority of the Director-General— |
| Retention Enema ........... | Colitis, ulcerative, proven by sigmoidoscopy or radiological report |
|
| Proctitis, proven by sigmoidoscopy |
130 | Methylprednisolone Acetate Injection | Intra-articular use |
131 | (1) Methyltestosterone Tablets, B.P. | Carcinoma of the breast |
|
| Eunuchism |
| (2) Methyl testosterone, B.P. ... | Eunuchoidism |
|
| Klinefelter's syndrome (seminiferous tubule dysgenesis) |
132 | Methysergide Maleate ........ | Treatment of severe recalcitrant migraine where other treatment has failed |
133 | Metyrapone .............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
134 | Minafen ................. | With the written authority of the Director-General, phenylketonuria |
135 | Morphine Sulphate, B.P. with Tacrine Tablets | Severe intractable pain |
136 | Mustine Hydrochloride Injection | Treatment in malignant neoplasia |
137 | Nalidixic Acid ............. | Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to nalidixic acid or where the patient is sensitive to sulphonamides |
138 | Nandrolone Decanoate ....... | Carcinoma of the breast |
|
| With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
|
| Severe osteoporosis due to proven pancreatitis |
139 | Nandrolone Hexoxyphenyl Propionate | Carcinoma of the breast |
|
| With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
140 | Nandrolone Phenylpropionate Injection, B.P. | Carcinoma of the breast |
|
| With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis |
142 | Neomycin Sulphate Powder .... | With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis) |
143 | Neomycin Tablets, B.P. ...... | Bowel sterilization preparatory to major surgery |
|
| Encephalopathy, hepatic |
|
| Enteropathogenic E. coli infections in infants |
144 | Nicotinic Acid Tablets, B.P. .... | Any disease or condition in a pensioner |
146 | (1) Nitrofurantoin Tablets, B.P. . | Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to nitrofurantoin or where the patient is sensitive to sulphonamides |
| (2) Nitrofurantoin Oral Suspension | |
147 | Nitromin ................ | Treatment in malignant neoplasia |
148 | Norethisterone Acetate, B.P. ... | Carcinoma of the breast |
148a | Norethisterone Tablets, B.P. .... | Endometriosis |
|
| Metrophathia haemorrhagica |
|
| Precocious puberty |
149 | Nutramigen .............. | With the written authority of the Director-General— |
|
| Cow's milk allergy in children under the age of four years |
Fifth Schedule—continued
First | Second Column | Third Column |
Item | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
|
|
|
149—cont. |
| Cystic Fibrosis (mucoviscidosis) Galactosaemia Lactose intolerance |
152 | Oxprenolol Hydrochloride Tablets | With the written authority of the Director-General— |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
153 | Oxprenolol Hydrochloride Injection | Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
154 | Oxycodone Pectinate ......... | Treatment in malignant neoplasia |
155 | Oxymetholone ............. | With the written authority of the Director-General, proven aplastic anaemias |
156 | (1) Pancreatin, B. P. .......... | Cystic Fibrosis (mucoviscidosis) |
| (2) Pancreatin Enzyme 4 X | Following pancreatico-duodenectomy |
| U.S.N.F. XII | Pancreatic steatorrhoea |
| (3) Pancrelipase |
|
157 | (1) Paracetamol Mixture ....... | Any disease or condition in a pensioner |
| (2) Paracetamol Tablets, B.P. |
|
158 | Paracetamol with Codeine Phosphate and Pentobarbitone Sodium | Any disease or condition in a pensioner |
159 | (l) Paraffin Liquid Emulsion .... | Any disease or condition in a pensioner |
| (2) Paraffin Liquid Emulsion with Phenolphthalein |
|
161 | Penicillamine .............. | With the written authority of the Director-General— |
|
| Acute heavy metal intoxication |
|
| Cystinosis |
|
| Cystinuria with calculus formation |
|
| Haemoglobinuria, paroxysmal cold |
|
| Wilson's disease (hepatolenticular degeneration) |
163 | Phytomenadione Injection, 10 mg. per ml. | Antidote to anticoagulants |
|
| Haemorrhage diathesis associated with malabsorption |
164 | Phytomenadione Injection, B.P., 1 mg. in 1 ml. | Antidote to anticoagulants |
|
| Suspected cerebral trauma of the new born |
|
| Hemorrhagic diathesis associated with malabsorption |
|
| Hemorrhagic disease of the new born |
165 | Pituitary, Posterior Lobe, Insufflation | Diabetes insipidus |
166 | Plasma Substitute (Polypeptide) .. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
166a | Polyisobutylene ............ | Ileostomy or colostomy conditions |
167 | Polymyxin B. Sulphate Powder .. | With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis) |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
|
|
|
168 | Polyoestradiol Phosphate ..... | Carcinoma of the breast |
|
| Carcinoma of the prostate |
169 | Prednisolone Sodium Phosphate | With the written authority of the Director-General— |
| Retention Enema and Suppository | Ulcerative colitis proven by sigmoidoscopy or radiological report |
|
| Proctitis proven by sigmoidoscopy |
170 | (1) Prednisolone Acetate Injection | Intra-articular use |
| (2) Prednisolone Butyl Acetate Injection |
|
171 | Prednisolone Sodium Succinate Injection | Acute adrenal cortical hypofunction due to any medical or surgical crisis |
|
| Prophylactic therapy before, during and after surgical procedures for patients undergoing or recently subject to steroid therapy |
172 | Procarbazine Hydrochloride ... | Treatment in malignant neoplasia |
173 | (1) Prochlorperazine ........ | Meniere's Syndrome |
| (2) Prochlorperazine Tablets, B.P. |
|
174 | Progesterone ............. | Progesterone deficiency proven by hormonal assay, by lateral wall smear or by endometrial biopsy |
175 | Propranolol Injection, B.P. .... | Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
176 | Propranolol Tablets, B.P. ..... | With the written authority of the Director-General— |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
176a | Proscillaridin ............. | Patients intolerant of oral forms of prepared digitalis, digoxin and lanatoside C |
177 | Prosobee ................ | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
178 | Pyrazinamide ............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
179 | (1) Pyridostigmine Injection, B.P. | Myasthenia gravis |
| (2) Pyridostigmine Tablets, B.P. |
|
180 | Pyridoxine Hydrochloride Tablets | Homocystinuria |
|
| Radiation sickness |
|
| Treatment and prophylaxis of peripheral neuritis caused or likely to be caused by isoniazid therapy |
|
| Sideroblastic (refractory anaemia) |
|
| Proven pyridoxine responsive anaemia |
|
| With the written authority of the Director General, primary hyperoxaluria |
182 | Riboflavine Tablets ......... | Any disease or condition in a pensioner |
182a | Senna Fruit Extract (standardised) | Any disease or condition in a pensioner |
Fifth Schedule—continued
First Column_Column | Third Column | |
Item | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
182b | Similac Isomil ........... | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
183 | Sobee ................. | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
184 | (1) Sodium Aminosalicylate Tablets, B.P. | Tuberculosis |
| (2) Sodium Aminosalicylate Injection |
|
| (3) Sodium Aminosalicylate Cachets |
|
| (4) Sodium Aminosalicylate Granules |
|
| (5) Sodium Aminosalicylate with Isoniazid, B.P. |
|
185 | Sodium Folate ........... | Proven folic acid deficiency |
|
| Sprue or the sprue-like syndrome |
186 | (1) Sodium Fusidate ....... | With the written authority of the Director-General, |
| (2) Diethanolamine Fusidate .. | the treatment of serious staphylococcal infections in a patient where it is established by appropriate bacteriological testing that Sodium Fusidate or Diethanolamine Fusidate in combination with another antibiotic is an appropriate therapy |
187 | Soyalac ................ | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
189 | Spironolactone Tablets, B.P. .. | With the written authority of the Director-General— |
|
| To supplement other diuretics when these have proved inadequate |
|
| Myasthenia gravis |
|
| Primary hyperaldosteronism |
190 | Stanolone .............. | Carcinoma of the breast |
|
| With the written authority of the Director-General— |
Intermittent use for corticosteroid-induced osteoporosis | ||
|
| Intermittent use for patients on long-term treatment with corticosteroids |
191 | Stanozolol .............. | With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
192 | Stilboestrol Diphosphate ..... | Carcinoma of the prostate |
193 | Streptokinase ............ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
194 | Sulphasalazine ........... | Ulcerative colitis |
196 | (1) Surgical Cement ........ | Ileostomy or colostomy conditions |
| (2) Surgical Cement Solvent .. | For use with surgical appliances |
197 | (1) Testosterone Propionate, B.P. with Testosterone Phenyl propionate, B.P. and Testosterone Iocaproate | Eunuchoidism |
| Eunuchism | |
| Klinefelter's syndrome (seminiferous tubule dysgenesis) | |
| (2) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate | Carcinoma of the breast |
Fifth Schedule—continued
First | Second Column | Third Column |
Item | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
197—cont. | (3) Testosterone Implants, B.P. |
|
| (4) Testosterone Enanthate |
|
| (5) Testosterone Propionate Injection, B.P. |
|
198 | Tetanus Antitoxin, B.P. (Bovine) | Patients who have previously received an injection of equine serum |
200 | Thiamine Hydrochloride Tablets, B.P. | Any disease or condition in a pensioner |
201 | Thiethylperazine Maleate Tablets and Suppositories | Radiation sickness |
|
| Nausea resulting from cytotoxic therapy |
202 | (1) Thioridazine Tablets, B.P. . | Any disease or condition in a pensioner |
| (2) Thioridazine | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| The treatment of a mental disorder in a person who has, after treatment for a. mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with either or both of the following pharmaceutical benefits— |
|
| Thioridazine |
|
| Thioridazine Tablets, B.P. |
|
| With the written authority of the Director-General— |
|
| Hereditary chorea (Huntington's) |
- |
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
203 | Thyrotrophin ............ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
204 | Tragacanth, Indian (Gum Karaya) | Ileostomy or colostomy conditions |
206 | Tretamine .............. | Treatment in malignant neoplasia |
207 | Triacetyloleandomycin ..... | Amoebiasis |
|
| Brucellosis |
|
| Leptospirosis |
|
| Lymphogranuloma venereum |
|
| Pneumonia due to mycoplasma pneumoniae |
|
| Pneumonia, staphylococcal |
|
| Psittacosis |
|
| Rickettsioses |
|
| Staphylococcal septicaemia |
|
| Actinomycosis, trachoma, or any bacterial or spirochaetal infections where these cannot be safely and effectively treated by sulphonamides, phenoxymethylpenicillin or phenethicillin |
207a | Triamcinolone Acetonide Injection | With the written authority of the Director-General, treatment of keloids |
208 | (1) Trifluoperazine Tablets, B.P. | Any disease or condition in a pensioner |
| (2) Trifluoperazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Trifluoperazine Hydrochloride, B.P. or Trifluoperazine Tablets, B.P. |
|
| With the written authority of the Director-General— |
|
| Hereditary chorea (Huntington's) |
|
| Malignant neoplasia (late stage) |
Fifth Schedule—continued
First Column_Column | Third Column | |
Item | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
|
|
|
208—cont. |
| Radiation sickness |
|
| The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
209 | Triglyde .................. | With the written authority of the Director-General, proven malabsorption |
211 | Trimethoprim with Sulphamethoxazole | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| Respiratory tract infections or urinary tract infections where positive bacteriological evidence shows trimethoprim with sulphamethoxazole to be effective |
214 | (1) Vinblastine Sulphate ........ | Treatment in malignant neoplasia |
| (2) Vincristine Sulphate |
|
215 | Vinyl Pyrrolidone and Vinyl Acetate with Benzocaine Aerosol Spray | Ileostomy or colostomy conditions |
216 | (1) Viomycin Sulphate ......... | Tuberculosis |
| (2) Viomycin Sulphate Injection, B.P. |
|
217 | Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D Tablets and Capsules | Any disease or condition in a pensioner |
Printed by Authority by the Government Printer of the Commonwealth of Australia